PATH
Menu

Filter browse results

Total results with these characteristics: 385

Subject: Reproductive health

Page 5 of 20
Microfinance and Women's Health: What Do We Know? (Outlook, vol. 28, no. 1)

This issue of Outlook reviews the evidence base for microfinance approaches to improve and address women’s health. It begins with background on the microfinance sector and links between microfinance and health. Interventions and approaches focused on family planning, women’s health services utilization and access (including health financing mechanisms), and HIV prevention are discussed. The issue concludes with suggested operational considerations for integration and priorities for future research. Some positive experiences with microfinance and women’s health signify that this area merits increased attention, yet more evidence of impact is needed.

Author: Drake JK

Publication date: August 2011

Region: Global

Part of series: Outlook

Home-Based Administration of depo-subQ provera 104™ in the Uniject™ Injection System

This literature review details the key findings on the feasibility and acceptability of home delivery of depo-subQ provera 104™ in the Uniject™ injection system  (depo-subQ in Uniject). The review focused on self-injection and looked specifically at subcutaneous depot medroxyprogesterone acetate (DMPA) compared to the intramuscular formulation; considerations for home administration of injectable contraception, particularly in low-resource settings; and identified research needs for home administration, including self-injection, of depo-subQ in Uniject. A six-page briefing summary of this review is also available.

Author: Keith BM

Publication date: July 2011

Region: Global

Recent Evidence on Cervical Cancer Screening in Low-Resource Settings

This Alliance for Cervical Cancer Prevention fact sheet summarizes evidence published since 2009 on cervical cancer screening approaches for low-resource settings.

Publication date: May 2011

Region: Global

Screening and Treatment to Reduce the Risk and Incidence of Cervical Cancer

This fact sheet provides an overview of PATH's work to prevent cervical cancer in Vietnam through the piloting of a "screen and treat" model in three provinces.

Publication date: May 2011

Region: Asia

Progress in Cervical Cancer Prevention: The CCA Report Card

This report assesses global readiness to fight cervical cancer using new approaches and new technologies, especially in regions where the disease is a common killer. It underscores the urgent need for the global community to prioritize cervical cancer prevention and control on global health and development agendas.

Publication date: April 2011

Region: Global

APHIA II Western Project: Best Practices and Promising Interventions

This report is a review of the USAID-funded AIDS, Population, and Health Integrated Assistance (APHIA II Western) Project, which operated at the provincial level in Western Kenya from December 2006 to December 2010. The project focused primarily on increasing the use of HIV/AIDS and tuberculosis health services, the adoption of healthier behaviors, the promotion of family planning and reproductive health services, and maternal and child health. The report is available as one large file or several smaller files.

Publication date: March 2011

Region: Africa

Assessing Demand for depo-subQ in Uniject: A Five-Country Modeling Exercise

This brief summarizes the strategic demand models developed by PATH and the Futures Institute for the injectable contraceptive depo-subQ provera 104™ in the Uniject™ injection system (depo-subQ in Uniject) in Kenya, Malawi, Pakistan, Rwanda, and Senegal. These models will help inform global and country introduction planning for depo-subQ in Uniject.

Publication date: February 2011

Region: Global

Logistics and Waste Management Benefits of depo-subQ in Uniject

This brief describes results from an analysis conducted by PATH comparing the current intramuscular version of depot medroxyprogesterone acetate (DMPA) injectable contraceptive compared with a new formulation packaged in the Uniject injection system. The analysis focused on waste management implications, identifying key quantitative and qualitative differences between the two products.

Publication date: February 2011

Region: Global

The Uniject Injection System: Multi-country Experience and Evidence

This brief summarizes key findings from a literature review conducted by PATH to identify published and gray literature reporting international experiences with the Uniject injection system. The findings shed light on user acceptability and highlight potential cost savings in terms of training time, waste management, and reduction in drug wastage when Uniject is used instead of a standard autodisable syringe. This document synthesizes the experience and evidence on the use of Uniject worldwide with medicines such as the injectable contraceptive Cyclofem®, hepatitis B and tetanus toxoid vaccines, as well as the drug oxytocin, which is used to prevent postpartum hemorrhage.

Publication date: February 2011

Region: Global

Building Effective, Sustainable Systems for Procuring Essential Reproductive Health Supplies

This white paper highlights the value of a comprehensive approach to procurement capacity development in developing countries.

Author: Cohen J, Reeh C, Neroutsos K

Publication date: January 2011

Region: Global

HPV Vaccination in Africa: Lessons Learned From a Pilot Program in Uganda

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Uganda by PATH, the Uganda National Expanded Program on Immunization of the Ministry of Health, and the Child Health and Development Centre, through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to almost 10,000 girls in select parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in sub-Saharan Africa, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: January 2011

Region: Global

Part of series: HPV vaccination project lessons learned reports

Access for All: The Secretariat of the Reproductive Health Supplies Coalition Annual Report 2010

The Reproductive Health Supplies Coalition is a global partnership dedicated to making essential reproductive health products available in low- and middle-income countries. As the Coalition’s administrative and operative arm, the Secretariat works to ensure that our partnership functions smoothly and achieves its goals. This report highlights key successes achieved in 2010.

Publication date: 2011

Region: Global

Developing a Total Market Plan for Family Planning in Vietnam: An Innovative Public and Private Collaboration to Enhance Equity and Sustainability

Since 2009, PATH has been working with government family planning officials to engage stakeholders and apply evidence to develop a total market plan for family planning in light of funding shortfalls. This case study in Vietnam is intended to highlight lessons learned and recommendations for those considering similar initiatives in other settings. It is a sister document to the Nicaragua case study, Developing Total Market Strategies for Family Planning in Nicaragua.

Author: Drake JK

Publication date: 2011

Region: Asia

Implementing HPV Vaccination Programs: Practical Experience From PATH

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It offers practical information to countries that plan to pilot, expand, or scale up human papillomavirus (HPV) vaccination programs. The main focus is on issues specific to HPV vaccination, such as working with a young adolescent target population in school settings and developing community support for HPV vaccination programs.

Publication date: 2011

Region: Global

Reproductive Health Commodity Security: Leading From Behind to Forge a Global Movement

It is widely recognized today that ensuring a reliable supply of quality contraceptives is essential to reproductive health programs. The tagline "No product? No program" is known, understood, and embraced by those working to support reproductive health in the developing world. But this was not always the case. This paper tells the story of how what was once seen only as a technical issue became a global movement.

Author: Solo J

Publication date: 2011

Region: Global

Strategic Planning and Situation Assessment for Cervical Cancer Prevention: Practical Experience From PATH

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It aims to help decision-makers and program planners focus on key “big picture” questions about cervical cancer prioritization and on opportunities and challenges for improved cancer prevention, including vaccination of girls and precancer screening and treatment of adult women.

Publication date: 2011

Region: Global

Directions in Global Health (Volume 7, Issue 2)

This issue of Directions in Global Health features a conversation with Chris Elias on the occasion of his ten-year anniversary as PATH’s president and CEO. It also highlights work to pave the way for a total market approach to family planning in Nicaragua and Vietnam, capitalize on the transformation potential of point-of-care tests, address gender’s impact on health, and design better health information systems for developing countries.

Publication date: December 2010

Region: Global

Part of series: Directions in Global Health

Evaluating HPV Vaccine Delivery Strategies in Vietnam

This report is a synthesis of the project Evaluating HPV Vaccine Delivery Strategies in Vietnam, which aimed to identify appropriate strategies for human papillomavirus (HPV) vaccine delivery in different geographic and socioeconomic conditions. The report summarizes results of both the implementation and research aspects of the project. The document is available as one large file or as four smaller files for easier downloading.

Publication date: December 2010

Region: Asia

HPV Vaccination in Latin America: Lessons Learned From a Pilot Program in Peru

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Peru by PATH, Instituto de Investigación Nutricional, and Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to all girls aged nine years or older in grade 5 in selected parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. The publication will be useful for policymakers and program managers around the world, and especially in Latin America, who are designing public-sector HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: December 2010

Region: Global

Part of series: HPV vaccination project lessons learned reports

Ability and Willingness to Pay for Family Planning in Vietnam

This study offers policy analysis of data previously collected on the ability and willingness to pay for family planning in Vietnam. PATH is helping the government of Vietnam to design a total market approach to family planning, which calls for a coordinated response by the full range of family planning service providers to meet a population’s diverse needs.

Author: Winfrey W

Publication date: November 2010

Region: Asia

Page 5 of 20